Comparison of Outpatient Rehabilitation Versus Self-training for the Treatment and Prevention of Postpartum Pelvic Floor Dysfunction
DDDPREV
Prevention of Female Pelvic Floor Dysfunction Rehabilitation Postpartum.
3 other identifiers
interventional
80
1 country
1
Brief Summary
The main goal of this study to compare self-training postpartum and training with a specialist support (physiotherapist and physical medicine and rehabilitation doctor) effect on pelvic floor dysfunction prevention and treatment in postpartum period. Hypothesis: The implementation of postpartum rehabilitation helps to alleviate existing symptoms of pelvic floor dysfunction and prevents pelvic floor dysfunction. Study goals:
- To objectively evaluate changes in pelvic organ position and pelvic floor muscle function in postpartum period, before and after specialised rehabilitation program
- To objectively evaluate pelvic floor symptoms and their influence on woman life quality
- To compare data (changes in pelvic floor muscle coordination and strength, pelvic organ position and changes in life quality according to validated questionnaires) Study participants will:
- Get an examination by obstetrician-gynaecologist, physical medicine and rehabilitation doctor and physiotherapist in 6 to 10 weeks postpartum period.
- One group of participants will attend physiotherapy, biofeedback and electro stimulation procedures with a guidance of a specialist.
- Other group of participants gets a recommendations and instructions of training and self-trains at home. To remind of training and help record training time "squeezy" app (an application designed for a mobile device) will be offered.
- All groups of participants will be asked to fill life quality related questionnaires: (ICIQ-UI SF: International Consultation on Incontinence Questionnaire; P-QoL: Prolapse Quality-of-Life Questionnaire; PISQ-IR: Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire IUGA revised; FSFI: female sexual function index; MOS-SF36 Medical Outcomes Study Short Form-36).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 17, 2026
CompletedFirst Posted
Study publicly available on registry
February 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2029
February 23, 2026
February 1, 2026
3.7 years
January 17, 2026
February 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Improvement in pelvic floor dysfunction symptoms
Self-reported improvement of symptoms (for example: pain, urinary incontinence, fecal incontinence, vaginal "laxity")
Asked at the beginning (first postpartum visit, 6-8 weeks postpartum), after first set of training (6months), after second set of training (12 months)
Change in PFM contraction force and strength according to the Modified Oxford Scale
Individual change in Oxford scores (0-5), bigger number means stronger contraction.
Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
Change in POP-Q scale
changes in POP-Q scales (especially in gh - genital hiatus, pb - perineal body, measured by centimeters, bigger number in gh means wider genital hiatus -worse outcome; smaller number in pb means thin perineal body - worse outcome)
Measured before starting the program, after first set of training (6 months from beginning) and after second set of training (12 months from beginning)
Change in life quality questionnaires ICIQ-UI SF
Quality of Life (QoL) and clinical outcome questionnaires: \* ICIQ-UI SF (International Consultation on Incontinence Questionnaire Short Form); scores 1-21, higher the number - worse outcome
Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).
Better voluntary pelvic floor muscle control
observation (compensatory muscles: abdominal, thighs, glutes movements during the contraction)
Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
Objectively measured change in pelvic floor muscle strength
Contraction measured with Myomed biofeedback device (manometry kPha)
Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
Quality of Life (QoL) and clinical outcome questionnaires: P-QoL
P-QoL (Prolapse Quality-of-Life Questionnaire) measures the impact of pelvic organ prolapse (POP) on a patient's life across eight domains, with total scores ranging from 0 (best) to 100 (worst). High scores indicate poor quality of life, while lower scores (often \<40 or \<20) indicate higher QOL and improvement after intervention
Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).
Quality of Life (QoL) and clinical outcome questionnaires: PISQ-IR
PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA revised) evaluates female sexual function (FSF) in women with pelvic floor disorders (PFD), using a 2.68 summary score cutoff for sexually active (SA) women to identify sexual dysfunction (values \>2.68 indicate no dysfunction). The survey separates patients into SA and not sexually active (NSA) groups. SA Scale: Higher scores indicate better sexual function. A mean score \\(\>2.68\\) suggests no dysfunction, with \\(90\\%\\) sensitivity and \\(73\\%\\) specificity.NSA Scale: Higher scores indicate a greater negative impact of pelvic floor disorders on sexual inactivity.
Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
Quality of Life (QoL) and clinical outcome questionnaires: FSFI (Female Sexual Function Index)
FSFI (Female Sexual Function Index) is a 19-item validated questionnaire assessing female sexual function over the past month, with total scores ranging from 2.0 to 36.0. A total score of ≤26.55 is the standard cutoff indicating a potential risk for Female Sexual Dysfunction (FSD). Higher scores indicate better, more robust sexual functioning
Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
Quality of Life (QoL) and clinical outcome questionnaires: MOS-SF36
MOS-SF36 (Medical Outcomes Study Short Form-36). s a 36-item, patient-reported survey measuring health-related quality of life across eight dimensions. Scores range from 0 to 100 for each subscale, with higher scores indicating better health functioning or fewer limitations. The survey evaluates physical, mental, and social health domains
Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
Secondary Outcomes (4)
Factors potentially influencing the effectiveness of the rehabilitation program: mean age
Asked and documented at first postpartum visit, 6-8 weeks postpartum
Other participant and birth related factors which may have influence on pelvic floor: BMI
Asked and documented at first postpartum visit, 6-8 weeks postpartum
Other participant and birth related factors which may have influence on pelvic floor: number of births
Asked and documented at first postpartum visit, 6-8 weeks postpartum
Other participant and birth related factors which may have influence on pelvic floor: mode of delivery
Asked and documented at first postpartum visit, 6-8 weeks postpartum
Study Arms (2)
Group of participants getting specialist supervised training postpartum
ACTIVE COMPARATORWoman 6-10 weeks postpartum starts training program with physiotherapist and physical medicine and rehabilitation physician supervision.
Group of participants doing self-training with an app
OTHERWoman 6-10 weeks postpartum starts self- training program at home. At the beginning they are instructed by physiotherapist and physical medicine and rehabilitation physician. This group use an app "squeezy" to remind the to do training and record training time.
Interventions
* 4 Times biofeedback training * 10 times physiotherapy with specialist * 10 times transcutaneal electrostimulation (TENS)
* training at home after physiotherapist instructions * using an app to record training frequency, length
Eligibility Criteria
You may qualify if:
- years or older
- This pregnancy was singleton
- No contraindications for physical activity
- No connective tissue disorders (for example Ehlers-Danlos syndrome)
- No neurological disorders to influence pelvic floor symptoms (for example clinically significant spinal disc herniation)
You may not qualify if:
- Younger than 18 years
- Twins or triplet pregnancy
- Contraindications for physical activity
- Connective tissue disorders
- Neurological disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vilnius Universitylead
- Vilnius University Hospital Santaros Klinikoscollaborator
- Vilnius Maternity Hospitalcollaborator
Study Sites (1)
Vilnius University: study centers: "Vilnius University Hospital " Santaros Clinic", "Vilniaus Gimdymo Namai"
Vilnius, Lithuania
Related Publications (4)
Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women Stephanie J WoodleyPeter LawrensonRhianon BoyleJune D CodySiv MørkvedAshleigh KernohanE Jean C Hay-Smith Version published: 07 May 2020
BACKGROUNDSigurdardottir T, Steingrimsdottir T, Geirsson RT, Halldorsson TI, Aspelund T, Bo K. Postpartum pelvic organ prolapse and pelvic floor muscle training: secondary analysis of a randomized controlled trial of primiparous women. Int Urogynecol J. 2023 Jun;34(6):1319-1326. doi: 10.1007/s00192-023-05502-8. Epub 2023 Mar 30.
PMID: 36995416BACKGROUNDBeamish NF, Davenport MH, Ali MU, Gervais MJ, Sjwed TN, Bains G, Sivak A, Deering RE, Ruchat SM. Impact of postpartum exercise on pelvic floor disorders and diastasis recti abdominis: a systematic review and meta-analysis. Br J Sports Med. 2025 Mar 31;59(8):562-575. doi: 10.1136/bjsports-2024-108619.
PMID: 39694630BACKGROUNDRomeikiene KE, Bartkeviciene D. Pelvic-Floor Dysfunction Prevention in Prepartum and Postpartum Periods. Medicina (Kaunas). 2021 Apr 16;57(4):387. doi: 10.3390/medicina57040387.
PMID: 33923810BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lina Būtėnaitė, MD, PhD
Vilnius University
- STUDY DIRECTOR
Daiva Bartkevičienė, Assoc. prof.
Vilnius University
- PRINCIPAL INVESTIGATOR
Eglė Pilkionytė, MD
Vilnius University
- PRINCIPAL INVESTIGATOR
Ivona Ivanovska, MD
Vilnius University
- PRINCIPAL INVESTIGATOR
Rūta Petravičienė
Vilnius University
- PRINCIPAL INVESTIGATOR
Karolina Eva Romeikienė, MD, PhD student
Vilnius University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Obstetrician-gynaecologist, PhD student, Karolina Eva Romeikiene
Study Record Dates
First Submitted
January 17, 2026
First Posted
February 23, 2026
Study Start
January 30, 2024
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2029
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- It is planned around september 2027-2028
- Access Criteria
- If other researches would like use data from this study they may ask for an IPD. Study protocol and results report will be shared with other researches as a future publication and in clinicaltrials.gov site.
Researchers may share de-identified individual participant data such like: age, bmi, pop-q scores etc. In excell or other analyzable data set.